• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

澳大利亚关键利益相关者对实施基于风险的人群乳腺癌筛查的看法——“我们要么上车,要么被车碾过” 。

Key stakeholders' perspectives on implementation of risk-based population breast cancer screening in Australia - "We can either get on the bus or get under it".

作者信息

Lippey Jocelyn, Keogh Louise, Best Stephanie, Purvis Rebecca, Mann Gregory Bruce, Forrest Laura

机构信息

Department of Surgery, St. Vincent's Hospital, 44 Victoria Pde, Fitzroy, Melbourne, VIC, 3065, Australia.

Department of Surgery, University of Melbourne, Parkville, Melbourne, VIC, 3052, Australia.

出版信息

Arch Public Health. 2025 Sep 1;83(1):223. doi: 10.1186/s13690-025-01690-5.

DOI:10.1186/s13690-025-01690-5
PMID:40890842
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12400751/
Abstract

BACKGROUND

Risk-based breast cancer screening would be a dramatic shift from the current one-size-fits-all model to a tailored approach where screening modality and frequency is directed by individual risk. This project assesses what key stakeholders, defined as those holding managerial and decision-making roles within BreastScreen, consider the issues are with implementing a risk-based approach to screening.

METHODS

A qualitative approach was undertaken, recruiting participants through professional networks with interviews guided by the Consolidated Framework of Implementation Research (CFIR). Participants were key stakeholders defined as those managing, overseeing and influencing Breast Screen throughout Australia. Data were deductively coded against a CFIR-informed codebook, followed by content analysis per CFIR domain.

RESULTS

Twenty interviews were conducted with 21 participants. 144 initial codes consolidated into 17 final themes. Key stakeholders are supportive and optimistic about risk-based screening in principle; however several issues exist, including knowledge gaps precluding support of evidence-based implementation. Concerns about worsening inequities within screening, cost and communication with clients are major issues key stakeholders consider important to address in the planning and implementing a change to the program.

CONCLUSIONS

Key stakeholders in Australia were overwhelmingly enthusiastic about the benefits of a risk-based approach however there are concerns about risk assessment utility, cost and the potential risk to equity in the program. Systematic assessment of these concerns will be required to facilitate successful change to the well-established breast screening program in Australia should risk-stratification be undertaken.

摘要

背景

基于风险的乳腺癌筛查将从当前的一刀切模式大幅转向一种量身定制的方法,即筛查方式和频率由个体风险决定。本项目评估了关键利益相关者(定义为在乳腺癌筛查机构中担任管理和决策角色的人员)认为实施基于风险的筛查方法存在哪些问题。

方法

采用定性研究方法,通过专业网络招募参与者,并以实施研究综合框架(CFIR)为指导进行访谈。参与者是关键利益相关者,定义为在澳大利亚各地管理、监督和影响乳腺癌筛查的人员。数据根据基于CFIR的编码手册进行演绎编码,然后按CFIR领域进行内容分析。

结果

对21名参与者进行了20次访谈。144个初始编码合并为17个最终主题。关键利益相关者原则上支持并看好基于风险的筛查;然而,存在一些问题,包括知识差距妨碍了对循证实施的支持。对筛查中不平等加剧、成本以及与客户沟通的担忧是关键利益相关者认为在规划和实施项目变革时需要解决的重要问题。

结论

澳大利亚的关键利益相关者对基于风险的方法的益处极为热情,但对风险评估效用、成本以及该项目中公平性的潜在风险存在担忧。如果要进行风险分层,需要对这些担忧进行系统评估,以促进澳大利亚成熟的乳腺癌筛查项目的成功变革。

相似文献

1
Key stakeholders' perspectives on implementation of risk-based population breast cancer screening in Australia - "We can either get on the bus or get under it".澳大利亚关键利益相关者对实施基于风险的人群乳腺癌筛查的看法——“我们要么上车,要么被车碾过” 。
Arch Public Health. 2025 Sep 1;83(1):223. doi: 10.1186/s13690-025-01690-5.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Stakeholders' perceptions and experiences of factors influencing the commissioning, delivery, and uptake of general health checks: a qualitative evidence synthesis.利益相关者对影响一般健康检查的委托、提供和接受因素的看法与体验:一项定性证据综合分析
Cochrane Database Syst Rev. 2025 Mar 20;3(3):CD014796. doi: 10.1002/14651858.CD014796.pub2.
4
Developing evidence-based guidelines for describing potential benefits and harms within patient information leaflets/sheets (PILs) that inform and do not cause harm (PrinciPILs).制定基于证据的指南,用于在患者信息单页/说明书(PrinciPILs)中描述潜在益处和危害,这些信息单页既能提供信息又不会造成伤害。
Health Technol Assess. 2025 Aug;29(43):1-20. doi: 10.3310/GJJH2402.
5
Health professionals' experience of teamwork education in acute hospital settings: a systematic review of qualitative literature.医疗专业人员在急症医院环境中团队合作教育的经验:对定性文献的系统综述
JBI Database System Rev Implement Rep. 2016 Apr;14(4):96-137. doi: 10.11124/JBISRIR-2016-1843.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
7
How to Implement Digital Clinical Consultations in UK Maternity Care: the ARM@DA Realist Review.如何在英国产科护理中实施数字临床会诊:ARM@DA实证主义综述
Health Soc Care Deliv Res. 2025 May 21:1-77. doi: 10.3310/WQFV7425.
8
The Lived Experience of Autistic Adults in Employment: A Systematic Search and Synthesis.成年自闭症患者的就业生活经历:系统检索与综述
Autism Adulthood. 2024 Dec 2;6(4):495-509. doi: 10.1089/aut.2022.0114. eCollection 2024 Dec.
9
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
10
Sexual Harassment and Prevention Training性骚扰与预防培训

本文引用的文献

1
Risk-adjusted breast screening: an Australian perspective and considerations for the Western Pacific.风险调整后的乳腺筛查:澳大利亚视角及西太平洋地区的考量
Lancet Reg Health West Pac. 2025 Mar 19;57:101520. doi: 10.1016/j.lanwpc.2025.101520. eCollection 2025 Apr.
2
AI-based selection of individuals for supplemental MRI in population-based breast cancer screening: the randomized ScreenTrustMRI trial.基于人工智能的个体选择用于基于人群的乳腺癌筛查中的补充 MRI:随机的 ScreenTrustMRI 试验。
Nat Med. 2024 Sep;30(9):2623-2630. doi: 10.1038/s41591-024-03093-5. Epub 2024 Jul 8.
3
Implementation considerations for risk-tailored cancer screening in the population: A scoping review.
风险定制癌症筛查在人群中的实施考虑因素:范围综述。
Prev Med. 2024 Apr;181:107897. doi: 10.1016/j.ypmed.2024.107897. Epub 2024 Feb 18.
4
Breast cancer screening: one size does not fit all.乳腺癌筛查:一刀切并不适用。
Lancet Oncol. 2023 Dec;24(12):1287. doi: 10.1016/S1470-2045(23)00590-9.
5
Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420).实时常规实施风险分层乳腺癌筛查与常规筛查相比的效果量化:BC-Predict 非随机对照研究(NCT04359420)。
Br J Cancer. 2023 Jun;128(11):2063-2071. doi: 10.1038/s41416-023-02250-w. Epub 2023 Apr 1.
6
Acceptability of risk stratification within population-based cancer screening from the perspective of the general public: A mixed-methods systematic review.基于公众视角的人群癌症筛查中风险分层的可接受性:一项混合方法系统评价。
Health Expect. 2023 Jun;26(3):989-1008. doi: 10.1111/hex.13739. Epub 2023 Feb 28.
7
Breast Cancer Risk Assessment Tools for Stratifying Women into Risk Groups: A Systematic Review.用于将女性分层为风险组的乳腺癌风险评估工具:一项系统评价。
Cancers (Basel). 2023 Feb 9;15(4):1124. doi: 10.3390/cancers15041124.
8
The updated Consolidated Framework for Implementation Research based on user feedback.基于用户反馈的更新的实施研究综合框架。
Implement Sci. 2022 Oct 29;17(1):75. doi: 10.1186/s13012-022-01245-0.
9
Healthcare professionals' views following implementation of risk stratification into a national breast cancer screening programme.实施风险分层后,医疗保健专业人员对国家乳腺癌筛查计划的看法。
BMC Cancer. 2022 Oct 12;22(1):1058. doi: 10.1186/s12885-022-10134-0.
10
Study protocol comparing the ethical, psychological and socio-economic impact of personalised breast cancer screening to that of standard screening in the "My Personal Breast Screening" (MyPeBS) randomised clinical trial.研究方案比较了“我的个人乳腺癌筛查”(MyPeBS)随机临床试验中个体化乳腺癌筛查与标准筛查的伦理、心理和社会经济影响。
BMC Cancer. 2022 May 6;22(1):507. doi: 10.1186/s12885-022-09484-6.